tiprankstipranks
Trending News
More News >
Chordia Therapeutics Inc. (JP:190A)
:190A
Japanese Market
Advertisement

Chordia Therapeutics Inc. (190A) Financial Statements

Compare
2 Followers

Chordia Therapeutics Inc. Financial Overview

Chordia Therapeutics Inc.'s market cap is currently ―. The company's EPS TTM is ¥-6.12; its P/E ratio is ―; Chordia Therapeutics Inc. is scheduled to report earnings on July 14, 2025, and the estimated EPS forecast is ¥―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 24Sep 23Sep 22Sep 21
Income Statement
Total Revenue¥ 0.00¥ 2.50B¥ 0.00¥ 800.00M
Gross Profit¥ -4.09M¥ 2.50B¥ -3.15M¥ 800.00M
Operating Income¥ -1.80B¥ 212.06M¥ -1.84B¥ -587.67M
EBITDA¥ -1.82B¥ 218.10M¥ -1.77B¥ -687.06M
Net Income¥ -1.83B¥ 223.34M¥ -1.78B¥ -527.11M
Balance Sheet
Cash & Short-Term Investments¥ 4.33B¥ 4.80B¥ 4.25B¥ 2.00B
Total Assets¥ 4.63B¥ 4.91B¥ 4.50B¥ 2.27B
Total Debt¥ 0.00¥ 0.00¥ 0.00¥ 0.00
Net Debt¥ -4.33B¥ -4.80B¥ -4.25B¥ -2.00B
Total Liabilities¥ 471.07M¥ 408.24M¥ 221.41M¥ 214.95M
Stockholders' Equity¥ 4.16B¥ 4.50B¥ 4.28B¥ 2.06B
Cash Flow
Free Cash Flow¥ -1.94B¥ 543.01M¥ -1.72B¥ -546.92M
Operating Cash Flow¥ -1.94B¥ 543.73M¥ -1.70B¥ -544.59M
Investing Cash Flow¥ -10.96M¥ 345.00K¥ -14.70M¥ -2.36M
Financing Cash Flow¥ 1.48B¥ 0.00¥ 3.98B¥ 1.53B
Currency in JPY

Chordia Therapeutics Inc. Earnings and Revenue History

Chordia Therapeutics Inc. Debt to Assets

Chordia Therapeutics Inc. Cash Flow

Chordia Therapeutics Inc. Forecast EPS vs Actual EPS

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis